How to Obtain AMA PRA Category 1 Credit™

  1. Click the link under “Next Step” (near bottom of this page) to open the journal article.
  2. Return to this page to advance to the CME posttest.
  3. Login to your myCME account.
  4. Complete the CME posttest.
  5. Complete the registration / evaluation form.
  6. Print your personalized CME certificate.

Technical Requirements

  

Volume 78, Number 5

Insulin treatment for type 2 diabetes: When to start, which to use

First Step: Review Information Below to Begin Activity

Release Date: May 1, 2011
Expiration Date: April 30, 2012

Description

Each learning activity within the Cleveland Clinic Journal of Medicine CME series is based on an article from the Cleveland Clinic Journal of Medicine, a post-test, and an evaluation.

Learning Objective

Readers will prescribe insulin appropriately to patients who have type 2 diabetes.

Target Audience

Directed to internists, endocrinologists, nephrologists, and other physicians.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Director

Brian F. Mandell, MD, PhD
Chairman, Department of Medicine, Education Institute
Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Editor-in-Chief, Cleveland Clinic Journal of Medicine
Cleveland Clinic
Cleveland, OH

Co-Activity Director

Timothy Gilligan, MD
Taussig Cancer Institute and Department of Bioethics
Deputy Editor, Cleveland Clinic Journal of Medicine
Cleveland Clinic
Cleveland, OH

Authors / Faculty

Marwan Hamaty, MD, MBA
Department of Endocrinology, Diabetes, and Metabolism,
Diabetes Center, Endocrine and Metabolism Institute, Cleveland Clinic,
Cleveland, OH

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:

 

Brian F. Mandell, MD, PhD (Activity Director)
  Fees for consulting and speaking (CME lectures):

Takeda Pharmaceuticals
  Paid independent contractor (clinical trials): Savient Pharmaceuticals
  Consultant: URL Pharma
  Section editor (rheumatology and immunology): The Merck Manual
     
Marwan Hamaty, MD, MBA
  Reviewer: Eli Lilly
  Principal investigator in the ORIGIN trial: Sanofi-Aventis
     

The following faculty have indicated they have no relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:

Timothy Gilligan, MD (Co-Activity Director)

All other CCJM staff report no relevant financial relationships.

Next Step:

(Article opens in new tab / window; return to this window to complete the activity).

Final Step:

Proceed to Posttest and Complete the CME Process

This CME activity was produced by the Cleveland Clinic Journal of Medicine and the Cleveland Clinic Center for Continuing Education.

CME Disclaimer